Especially, the 5-year survival rate of patients with E-cadherin-negative T1 tumours was significantly lower than that of patients with E-cadherin-positive T1 tumours (79.1 vs 59.8%, P=0.0328, Figure 3B). Here, CDH1 is linked to neoplasm.